Ekso Bionics Holdings, Inc.
EKSO
$12.37
$0.373.08%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.14M | 4.23M | 2.06M | 3.38M | 5.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.14M | 4.23M | 2.06M | 3.38M | 5.09M |
| Cost of Revenue | 1.47M | 1.68M | 1.24M | 1.57M | 2.38M |
| Gross Profit | 1.67M | 2.55M | 819.00K | 1.81M | 2.71M |
| SG&A Expenses | 5.40M | 3.40M | 3.94M | 4.08M | 4.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.90M | 5.63M | 6.03M | 6.64M | 7.32M |
| Operating Income | -3.76M | -1.40M | -3.98M | -3.26M | -2.23M |
| Income Before Tax | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M |
| EBIT | -3.76M | -1.40M | -3.98M | -3.26M | -2.23M |
| EBITDA | -3.31M | -1.04M | -3.60M | -2.88M | -1.83M |
| EPS Basic | -1.46 | -0.54 | -1.24 | -1.71 | -2.08 |
| Normalized Basic EPS | -0.77 | -0.34 | -0.78 | -1.00 | -1.30 |
| EPS Diluted | -1.46 | -0.54 | -1.24 | -1.71 | -2.08 |
| Normalized Diluted EPS | -0.77 | -0.34 | -0.78 | -1.00 | -1.30 |
| Average Basic Shares Outstanding | 3.21M | 2.62M | 2.18M | 1.69M | 1.64M |
| Average Diluted Shares Outstanding | 3.21M | 2.62M | 2.18M | 1.69M | 1.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |